Frequency of Hepatopulmonary Syndrome (HPS) Among Patients With Liver Cirrhosis: A Letter to Editor

authors:

avatar Ali Mokhtarifar 1 , avatar Hamidreza Azimi 1 , avatar Abbas Esmaeelzadeh 1 , avatar Mahmood Ebrahimi 2 , avatar Seyed Ahmad Eghbali 1 , *

Department of Gastroenterology, Mashhad University of Medical Sciences, Mashhad, IR Iran
Department of Cardiology, Mashhad University of Medical Sciences, Mashhad, IR Iran
Hepatitis Monthly: Vol.16, issue 2; e35990
published online: February 27, 2016
article type: Letter
received: January 2, 2016
accepted: January 25, 2016
DOI: https://doi.org/10.5812/hepatmon.35990

how to cite: Mokhtarifar A, Azimi H, Esmaeelzadeh A, Ebrahimi M, Eghbali S A. Frequency of Hepatopulmonary Syndrome (HPS) Among Patients With Liver Cirrhosis: A Letter to Editor. Hepat Mon. 2016;16(2):e35990. https://doi.org/10.5812/hepatmon.35990.

References

  • 1.

    Rodriguez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med. 2008;358(22):2378-87. [PubMed ID: 18509123]. https://doi.org/10.1056/NEJMra0707185.

  • 2.

    Kaymakoglu S, Kahraman T, Kudat H, Demir K, Cakaloglu Y, Adalet I, et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci. 2003;48(3):556-60. [PubMed ID: 12757170].

  • 3.

    Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC, et al. Hepatopulmonary syndrome in patients with hypoxic hepatitis. Gastroenterology. 2006;131(1):69-75. [PubMed ID: 16831591]. https://doi.org/10.1053/j.gastro.2006.04.014.

  • 4.

    Rodriguez-Roisin R, Krowka MJ, Herve P, Fallon MB, E. R. S. Task Force Pulmonary-Hepatic Vascular Disorders Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004;24(5):861-80. [PubMed ID: 15516683]. https://doi.org/10.1183/09031936.04.00010904.

  • 5.

    Fritz JS, Fallon MB, Kawut SM. Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med. 2013;187(2):133-43. [PubMed ID: 23155142]. https://doi.org/10.1164/rccm.201209-1583CI.

  • 6.

    Krowka MJ, Cortese DA. Hepatopulmonary syndrome: An evolving perspective in the era of liver transplantation. Hepatology. 1990;11(1):138-42. https://doi.org/10.1002/hep.1840110123.

  • 7.

    Krowka MJ. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. CHEST Journal. 1994;105(5):1528. https://doi.org/10.1378/chest.105.5.1528.

  • 8.

    Schenk P, Schöniger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Müller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology. 2003;125(4):1042-52. https://doi.org/10.1016/s0016-5085(03)01207-1.

  • 9.

    Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest. 1990;97(5):1165-70. [PubMed ID: 2331913].

  • 10.

    Stoller JK, Lange PA, Westveer MK, Carey WD, Vogt D, Henderson JM. Prevalence and reversibility of the hepatopulmonary syndrome after liver transplantation. The Cleveland Clinic experience. West J Med. 1995;163(2):133-8. [PubMed ID: 7571560].

  • 11.

    Hopkins WE, Waggoner AD, Barzilai B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol. 1992;70(4):516-9. https://doi.org/10.1016/0002-9149(92)91200-n.

  • 12.

    Arguedas MR, Singh H, Faulk DK, Fallon MB. Utility of pulse oximetry screening for hepatopulmonary syndrome. Clin Gastroenterol Hepatol. 2007;5(6):749-54. [PubMed ID: 17392034]. https://doi.org/10.1016/j.cgh.2006.12.003.